SCHEMBL24985595

SCHEMBL24985595

COc1nc(Cl)c2c(Cl)nc(Cl)nc2c1F

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26932615 0.87 CYP1A2 (0.40) CYP1A2
SCHEMBL31196790 0.76 CYP1A2 (0.30) CYP1A2
SCHEMBL30253888 0.76 CYP1A2 (0.33) CYP1A2
SCHEMBL25081811 0.76 CYP1A2 (0.33) CYP1A2
SCHEMBL24663880 0.76 — —
SCHEMBL25136998 0.76 TSHR (0.32) —
SCHEMBL31196801 0.76 TSHR (0.32) —
SCHEMBL30427115 0.76 ALDH1A1 (0.32) —
SCHEMBL24663882 0.76 ALDH1A1 (0.32) —
SCHEMBL12599750 0.75 CYP1A2 (0.47) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001141-A1 KRAS G12D INHIBITORS AND USES THEREOF SHANGHAI ZION PHARMA CO. LIMITED (CN) 2023-01-26 — — WO disclosed
Send feedback